Special Delivery $19.043M Market Capitalization Lexaria Bioscience Corp. (LEXX.Q) is a biotechnology company developing DehydraTECH™, the Company’s proprietary drug delivery technology. In addition to enhancing the speed and efficiency of…
drug delivery system
Digital Medicine Society The world is on fire, inflation is through the roof, and there is a literal war occurring in Ukraine. While I believe it is important…
A Fundamental Problem The opioid crisis has spread like an epidemic across North America. Between January 2016 and March 2019, an estimated 12,800 Canadians died from apparent opioid-related overdoses…
Sector Summary The medical sector is a doozy. From cancer to cardiovascular diseases, areas of high unmet medical need are appearing faster than they can be dealt with. According…
Lexaria Bioscience (LLX.C) announced today that treatment and dosing in its human clinical study, HYPER-H21-1, have been completed ahead of schedule. “Completing this work in the midst of…
Heritage Cannabis Holdings (CANN.C) RAD and feelgood. brand have launched for order in Manitoba today, according to a press release. The feelgood. brand is brand new, introduced yesterday as…
CANN focuses on extraction and the creation of derivative products for recreational and medical consumers….
Xphyto Therapeutics (XPHY.C) diagnostic partner, 3a-Diagnostics GmbH, is getting onboard with the latest rush to develop a COVID-19 diagnostic kit, using reverse transcription polymerase chain reaction (RT-PCR) technology, which…
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”…
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate…